Search
Virax Biolabs Group Ltd
VRAXAdd to Watchlist
3.130USD
+0.390+14.23%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
13.59MMarket Cap
LossP/E TTM
More Details of Virax Biolabs Group Ltd Company
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Virax Biolabs Group Ltd Info
Ticker SymbolVRAX
Company nameVirax Biolabs Group Ltd
IPO dateJul 14, 2022
CEOFoster (James)
Number of employees19
Security typeOrdinary Share
Fiscal year-endJul 14
AddressBiocity Glasgow
CityLONDON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeML1 5UH
Phone4402077887414
Websitehttps://www.viraxbiolabs.com
Ticker SymbolVRAX
IPO dateJul 14, 2022
CEOFoster (James)
Company Executives of Virax Biolabs Group Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
11.52K
--
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
613.00
--
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
11.52K
--
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
613.00
--
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Virax Biolabs Group Ltd?
The top five shareholders of Virax Biolabs Group Ltd are: Mr. James Foster
How many institutions hold shares of Virax Biolabs Group Ltd (VRAX)?
As of 2026Q1, 22 institutions hold shares of Virax Biolabs Group Ltd, with a combined market value of approximately 851.39K, accounting for 4.27% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 268600.00.